BRPI0820450A2 - Comprimidos revestidos de filme contendo drospirenona como agente ativo e um método para a preparação dos mesmos - Google Patents
Comprimidos revestidos de filme contendo drospirenona como agente ativo e um método para a preparação dos mesmosInfo
- Publication number
- BRPI0820450A2 BRPI0820450A2 BRPI0820450-0A BRPI0820450A BRPI0820450A2 BR PI0820450 A2 BRPI0820450 A2 BR PI0820450A2 BR PI0820450 A BRPI0820450 A BR PI0820450A BR PI0820450 A2 BRPI0820450 A2 BR PI0820450A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- film
- active agent
- coated tablets
- tablets containing
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title 1
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title 1
- 229960004845 drospirenone Drugs 0.000 title 1
- 239000007941 film coated tablet Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0700826A HUP0700826A3 (en) | 2007-12-20 | 2007-12-20 | Coated tablet containing drospirenone and process for producing the same |
| PCT/HU2008/000100 WO2009081216A1 (en) | 2007-12-20 | 2008-09-02 | Film coated tablets containing drospirenone as active agent and a method for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0820450A2 true BRPI0820450A2 (pt) | 2015-06-16 |
Family
ID=89987951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0820450-0A BRPI0820450A2 (pt) | 2007-12-20 | 2008-09-02 | Comprimidos revestidos de filme contendo drospirenona como agente ativo e um método para a preparação dos mesmos |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20110002993A1 (pt) |
| EP (2) | EP2446880A1 (pt) |
| JP (1) | JP5679819B2 (pt) |
| CN (1) | CN101896166B (pt) |
| AU (1) | AU2008339588B2 (pt) |
| BR (1) | BRPI0820450A2 (pt) |
| CA (1) | CA2708875A1 (pt) |
| CY (1) | CY1113416T1 (pt) |
| DK (1) | DK2072041T3 (pt) |
| EA (1) | EA017869B1 (pt) |
| ES (1) | ES2391953T3 (pt) |
| HK (1) | HK1147054A1 (pt) |
| HR (1) | HRP20120815T1 (pt) |
| HU (1) | HUP0700826A3 (pt) |
| IL (1) | IL205818A (pt) |
| MY (1) | MY148138A (pt) |
| NZ (1) | NZ585554A (pt) |
| PL (1) | PL2072041T3 (pt) |
| PT (1) | PT2072041E (pt) |
| SI (1) | SI2072041T1 (pt) |
| UA (1) | UA103182C2 (pt) |
| WO (1) | WO2009081216A1 (pt) |
| ZA (1) | ZA201003913B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160048305A1 (en) * | 2014-08-14 | 2016-02-18 | Microsoft Corporation | Group-Based User Interface Rearrangement |
| US10232045B2 (en) * | 2016-08-04 | 2019-03-19 | Bpsi Holdings Llc | Easy to swallow coatings and substrates coated therewith |
| CN111655147A (zh) * | 2018-01-29 | 2020-09-11 | 普和希控股公司 | 生物传感器探针用保护膜材料 |
| US20210000393A1 (en) * | 2018-03-13 | 2021-01-07 | Phc Holdings Corporation | Protective film material for biosensor probe |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652761C2 (de) | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE3022337A1 (de) | 1980-06-11 | 1982-01-07 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen |
| KR100857344B1 (ko) * | 1999-08-31 | 2008-09-05 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 피임약으로서의 사용을 위한 에티닐에스트라디올과드로스피렌온의 약학적 조합 |
| US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
| JP2004315713A (ja) * | 2003-04-18 | 2004-11-11 | Shin Etsu Chem Co Ltd | 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物 |
| EP1625849A1 (en) * | 2004-08-09 | 2006-02-15 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
| US8475838B2 (en) * | 2005-06-03 | 2013-07-02 | Sandoz Ag | Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| EP1767194A1 (de) * | 2005-06-09 | 2007-03-28 | Helm AG | Verfahren zur Herstellung von Adsorbaten des Drospirenons |
-
2007
- 2007-12-20 HU HU0700826A patent/HUP0700826A3/hu unknown
-
2008
- 2008-09-02 CN CN2008801205209A patent/CN101896166B/zh active Active
- 2008-09-02 MY MYPI2010002356A patent/MY148138A/en unknown
- 2008-09-02 CA CA2708875A patent/CA2708875A1/en not_active Abandoned
- 2008-09-02 US US12/809,441 patent/US20110002993A1/en not_active Abandoned
- 2008-09-02 UA UAA201009145A patent/UA103182C2/ru unknown
- 2008-09-02 BR BRPI0820450-0A patent/BRPI0820450A2/pt not_active Application Discontinuation
- 2008-09-02 JP JP2010538923A patent/JP5679819B2/ja active Active
- 2008-09-02 NZ NZ585554A patent/NZ585554A/en unknown
- 2008-09-02 WO PCT/HU2008/000100 patent/WO2009081216A1/en active Application Filing
- 2008-09-02 EA EA201001032A patent/EA017869B1/ru unknown
- 2008-09-02 AU AU2008339588A patent/AU2008339588B2/en active Active
- 2008-10-06 PT PT08462008T patent/PT2072041E/pt unknown
- 2008-10-06 DK DK08462008.7T patent/DK2072041T3/da active
- 2008-10-06 EP EP12151732A patent/EP2446880A1/en not_active Withdrawn
- 2008-10-06 ES ES08462008T patent/ES2391953T3/es active Active
- 2008-10-06 EP EP08462008A patent/EP2072041B1/en not_active Revoked
- 2008-10-06 PL PL08462008T patent/PL2072041T3/pl unknown
- 2008-10-06 SI SI200830763T patent/SI2072041T1/sl unknown
-
2010
- 2010-05-17 IL IL205818A patent/IL205818A/en active IP Right Grant
- 2010-06-01 ZA ZA2010/03913A patent/ZA201003913B/en unknown
-
2011
- 2011-02-01 HK HK11101080.6A patent/HK1147054A1/xx unknown
-
2012
- 2012-10-05 CY CY20121100930T patent/CY1113416T1/el unknown
- 2012-10-11 HR HRP20120815AT patent/HRP20120815T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2072041T3 (da) | 2012-11-05 |
| SI2072041T1 (sl) | 2012-11-30 |
| ES2391953T3 (es) | 2012-12-03 |
| EA017869B1 (ru) | 2013-03-29 |
| AU2008339588B2 (en) | 2014-06-26 |
| EP2072041B1 (en) | 2012-08-01 |
| HRP20120815T1 (hr) | 2012-11-30 |
| CN101896166A (zh) | 2010-11-24 |
| IL205818A0 (en) | 2010-11-30 |
| HU0700826D0 (en) | 2008-02-28 |
| WO2009081216A1 (en) | 2009-07-02 |
| EP2072041A1 (en) | 2009-06-24 |
| EP2446880A1 (en) | 2012-05-02 |
| HUP0700826A2 (en) | 2009-07-28 |
| PL2072041T3 (pl) | 2012-12-31 |
| AU2008339588A1 (en) | 2009-07-02 |
| CY1113416T1 (el) | 2016-06-22 |
| MY148138A (en) | 2013-02-28 |
| CA2708875A1 (en) | 2009-07-02 |
| HK1147054A1 (en) | 2011-07-29 |
| JP2011507825A (ja) | 2011-03-10 |
| IL205818A (en) | 2016-05-31 |
| PT2072041E (pt) | 2012-10-31 |
| HUP0700826A3 (en) | 2010-03-29 |
| CN101896166B (zh) | 2013-05-01 |
| ZA201003913B (en) | 2011-03-30 |
| US20110002993A1 (en) | 2011-01-06 |
| NZ585554A (en) | 2012-06-29 |
| EA201001032A1 (ru) | 2010-12-30 |
| UA103182C2 (ru) | 2013-09-25 |
| JP5679819B2 (ja) | 2015-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1249363A1 (zh) | 包含生物防治劑和殺蟲劑的組合物 | |
| IL253138A0 (en) | Preparations containing a biological control agent and an insecticide | |
| EP2792746A4 (en) | OLIGONUCLEOTIDE AND THERAPEUTIC FOR HYPERLIPIDEMIA WITH THIS AS AN ACTIVE SUBSTANCE | |
| BRPI0917358A2 (pt) | formulação farmacêutica de liberação controlada e método. | |
| ZA201503361B (en) | Composition comprising a biological control agent and an insecticide | |
| IL235818B (en) | Preparations containing a biological control agent and an insecticide | |
| ZA201209424B (en) | Method for delivering an active agent | |
| DK2073860T3 (da) | Lægemiddelfrigivende coatinger til medicinske indretninger | |
| BR112015000441A2 (pt) | imunoconjugados, formulação farmacêutica e método de tratamento e método para inbir a proliferação de uma célula positiva para cd22 | |
| BRPI1014229A2 (pt) | método para prover desenvolvimento do gerenciamento de terapia, e, plataforma de desenvolvimento de gerenciamento de terapia | |
| ZA201408237B (en) | Compositions comprising a biological control agent and an insecticide | |
| IL222012A (en) | Controlled-release dosage forms for high-dose hygroscopic and water-soluble pharmaceuticals | |
| DK3360575T3 (da) | Transdermale farmaceutiske sammensætninger omfattende aktive stoffer | |
| BR112013010102A2 (pt) | microagulha, arranjo de microagulhas, dispositivo de microagulhas, e, método para administrar um agente medicinal | |
| BRPI0814986A2 (pt) | Métodos e dispositivos para a distribuição de fármaco desmopresina. | |
| IL235545A (en) | Preparations containing biological control and insecticide | |
| BRPI0915284A2 (pt) | Composição famacêutica oral, método para tratar uma infecção fúngica e para tratar câncer em um mamífero, e, formulação de liberação prolongada oral | |
| BR112013014203A2 (pt) | peptídeo anfifílico bicéfalo, hidrogel e método para liberação de um agente bioativo | |
| EP2612914A4 (en) | OLIGONUCLEOTIDE, AND THERAPEUTIC AGENT FOR DYSLIPIDEMIA CONTAINING OLIGONUCLEOTIDE AS ACTIVE INGREDIENT | |
| EP2407472A4 (en) | POLYFLUOROALKYLPHOSPHONIC ACID, PROCESS FOR PRODUCING THE SAME, AND REAGENT FOR DEMOWLING IT AS ACTIVE INGREDIENT | |
| CL2008000719A1 (es) | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a | |
| BR112015001843A2 (pt) | dispositivo médico, composição de matriz biodegradável e método para tratar um paciente. | |
| BRPI0820450A2 (pt) | Comprimidos revestidos de filme contendo drospirenona como agente ativo e um método para a preparação dos mesmos | |
| BRPI0921901A2 (pt) | embalagem para contenção de artigos de fumo | |
| HK1201812A1 (en) | Insolubilizing agent for specific toxic substances, method for insolubilizing specific toxic substances using same, and soil improvement method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |